John W Smither
CIK 1559583 · Chief Financial Officer · last filed 2026-01-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.93M
Companies
9
Total Filings
73
Lifetime Open-Market Net
-$8.63M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAMSW | Director | 10,360 | $18.80 | $194.8K | $0 | 3 | 2026-01-09 |
| GNLX | Director | 74,994 | $2.96 | $222.0K | -$18.7K | 6 | 2025-08-29 |
| ARQT | Chief Financial Officer | 144,185 | $24.38 | $3.52M | -$619.5K | 12 | 2024-02-15 |
| Applied Molecular Transport Inc. (AMTI) Delisted | Director | — | $0.26 | — | $0 | 4 | 2023-12-28 |
| eFFECTOR Therapeutics, Inc. (EFTRW) Delisted | Director | 24,142 | $0.00 | $14 | $0 | 5 | 2023-06-22 |
| Principia Biopharma Inc. (PRNB) Delisted | Director | — | — | — | $0 | 1 | 2019-02-21 |
| Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Chief Financial Officer | 81,618 | — | — | $0 | 3 | 2019-01-03 |
| Achaogen, Inc. (AKAO) Delisted | Director | — | — | — | $0 | 5 | 2018-06-07 |
| KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Chief Financial Officer | 0 | — | — | -$7.99M | 34 | 2015-10-02 |
Recent Filings · Page 6 of 8
73 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-01-27 | KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Mixed | −25,416 | -$106.9K | EDGAR |
| 2015-01-06 | KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Exer (M) | +6,216 | $8.4K | EDGAR |
| 2014-12-22 | KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Mixed | — | -$10.2K | EDGAR |
| 2014-11-20 | KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Mixed | — | -$10.0K | EDGAR |
| 2014-10-20 | KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Mixed | — | -$9.1K | EDGAR |
| 2014-09-22 | KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Mixed | — | -$10.3K | EDGAR |
| 2014-08-20 | KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Mixed | — | -$10.1K | EDGAR |
| 2014-07-21 | KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Mixed | — | -$9.4K | EDGAR |
| 2014-07-03 | KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Mixed | — | -$71.5K | EDGAR |
| 2014-03-27 | KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | Exer (M) | +3,000 | $4.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.